Categories: HealthcareNews

Avantor® to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

RADNOR, Pa., Jan. 3, 2025 /PRNewswire/ — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that Michael Stubblefield, President and CEO, will present at the 43rd Annual J.P. Morgan Healthcare Conference at The Westin St. Francis Hotel in San Francisco on Wednesday, January 15, 2025 at approximately 8:15 a.m. Pacific Standard Time.

To hear a live audio webcast of the session, visit Events & Presentations in the Investor section of Avantor’s website, ir.avantorsciences.com. A replay of the webcast will be available for 30 days.

About Avantor
Avantor® is a leading life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. We work side-by-side with customers at every step of the scientific journey to enable breakthroughs in medicine, healthcare, and technology. Our portfolio is used in virtually every stage of the most important research, development and production activities at more than 300,000 customer locations in 180 countries. For more information, visit avantorsciences.com and find us on LinkedInX (Twitter) and Facebook.

Investor Relations Contact
Christina Jones
Vice President, Investor Relations
Avantor
805-617-5297
Christina.Jones@avantorsciences.com

Global Media Contact
Eric Van Zanten
Head of External Communications
Avantor
610-529-6219
Eric.VanZanten@avantorsciences.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/avantor-to-participate-in-the-43rd-annual-jp-morgan-healthcare-conference-302341283.html

SOURCE Avantor and Financial News

Staff

Recent Posts

Awakn Life Sciences Announces Completion of Arrangement and Sale to Solvonis Therapeutics plc

Toronto, Ontario--(Newsfile Corp. - May 27, 2025) - Awakn Life Sciences Corp. (CSE: AWKN) (OTC…

8 minutes ago

HemoSonics Wins Best Medical Device Company in Triangle Business Journal’s 2025 Life Sciences Awards

HemoSonics’ Quantra Hemostasis System provides comprehensive blood analysis detailing hemostasis in the operating room in…

1 hour ago

Alzheimer’s Association Launches Free Mobile App to Support Newly Diagnosed Individuals and Care Partners

– New app developed with input from people living with early-stage dementia, connects families affected…

1 hour ago

Global Surge in Analytical and Life Science Tools to Push Market Beyond $100 Billion by 2029, New SDi Report Predicts

ARLINGTON, Va., May 27, 2025 /PRNewswire/ -- Strategic Directions International (SDi), part of Science and…

1 hour ago

Chromatography Accessories & Consumables Market worth US$8.74 billion by 2030 with 7.5% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., May 27, 2025 /PRNewswire/ -- The global Chromatography Accessories & Consumables Market, valued…

1 hour ago

Life365 Appoints Healthcare Veteran Jay Roberts as Chief Development Officer

Industry Leader with 30+ Years of Experience Will Drive Strategic Growth and Partnerships SCOTTSDALE, Ariz.,…

1 hour ago